Report copyright - A Phase 1, First-in-Human, Open-Label, Dose Escalation ......Treatment related SAEs (n=6) include Gr3 myocarditis, Gr3 enteritis, Gr3 enterocolitis, Gr2 arthralgia, Gr2 pneumonitis,
Please pass captcha verification before submit form